Regulation of the master regulator FOXM1 in cancer

被引:282
|
作者
Liao, Guo-Bin [1 ]
Li, Xin-Zhe [1 ]
Zeng, Shuo [1 ]
Liu, Cheng [1 ]
Yang, Shi-Ming [1 ]
Yang, Li [1 ]
Hu, Chang-Jiang [1 ]
Bai, Jian-Ying [1 ]
机构
[1] Army Med Univ, Xinqiao Hosp, Dept Gastroenterol, Third Mil Med Univ, Chongqing 400037, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
FOXM1; Regulation; Transcriptional; Post-transcriptional; Post-translational; FORKHEAD BOX M1; TRANSCRIPTION FACTOR FOXM1; POSITIVE FEEDBACK LOOP; EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN HEPATOCELLULAR-CARCINOMA; POTENTIAL PROGNOSTIC MARKER; HUMAN CERVICAL-CANCER; CELL LUNG-CANCER; TARGETING FOXM1; BREAST-CANCER;
D O I
10.1186/s12964-018-0266-6
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
FOXM1 (forkhead box protein M1) is a critical proliferation-associated transcription factor that is widely spatiotemporally expressed during the cell cycle. It is closely involved with the processes of cell proliferation, self-renewal, and tumorigenesis. In most human cancers, FOXM1 is overexpressed, and this indicates a poor prognosis for cancer patients. FOXM1 maintains cancer hallmarks by regulating the expression of target genes at the transcriptional level. Due to its potential role as molecular target in cancer therapy, FOXM1 was named the Molecule of the Year in 2010. However, the mechanism of FOXM1 dysregulation remains indistinct. A comprehensive understanding of FOXM1 regulation will provide novel insight for cancer and other diseases in which FOXM1 plays a major role. Here, we summarize the transcriptional regulation, post-transcriptional regulation and post-translational modifications of FOXM1, which will provide extremely important implications for novel strategies targeting FOXM1.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] FoxM1 dances with mitosis
    Robert H. Costa
    Nature Cell Biology, 2005, 7 : 108 - 110
  • [42] Honokiol is a FOXM1 antagonist
    Marianna Halasi
    Ben Hitchinson
    Binal N. Shah
    Renáta Váraljai
    Irum Khan
    Elizaveta V. Benevolenskaya
    Vadim Gaponenko
    Jack L. Arbiser
    Andrei L. Gartel
    Cell Death & Disease, 9
  • [43] Honokiol is a FOXM1 antagonist
    Halasi, Marianna
    Hitchinson, Ben
    Shah, Binal N.
    Varaljai, Renata
    Khan, Irum
    Benevolenskaya, Elizaveta V.
    Gaponenko, Vadim
    Arbiser, Jack L.
    Gartel, Andrei L.
    CELL DEATH & DISEASE, 2018, 9
  • [44] Prognostic significance of FOXM1 expression and antitumor effect of FOXM1 inhibition in synovial sarcomas
    Maekawa, Akira
    Kohashi, Kenichi
    Kuda, Masaaki
    Iura, Kunio
    Ishii, Takeaki
    Endo, Makoto
    Nakatsura, Tetsuya
    Iwamoto, Yukihide
    Oda, Yoshinao
    BMC CANCER, 2016, 16
  • [45] FoxM1 dances with mitosis
    Costa, RH
    NATURE CELL BIOLOGY, 2005, 7 (02) : 108 - 110
  • [46] FoxM1 is overexpressed in human hepatocellular cancer and associated with cancer progression
    Wu, Qifei
    Liu, Chang
    Yu, Min
    Liu, Dong
    Tai, Min Hui
    Tian, Min
    Lv, Yi
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2010, 211 (03) : S125 - S125
  • [47] FOXM1 cistrome predicts breast cancer metastatic outcome better than FOXM1 expression levels or tumor proliferation index
    Christina Yau
    Laurence Meyer
    Stephen Benz
    Charles Vaske
    Gary Scott
    Brian Egan
    Paul Labhart
    Nader Pourmand
    Christopher C. Benz
    Breast Cancer Research and Treatment, 2015, 154 : 23 - 32
  • [48] Pan-Cancer Upregulation of the FOXM1 Transcription Factor
    Pozzobon, Daniele
    Bellezza, Arianna
    Giorgi, Federico M.
    GENES, 2025, 16 (01)
  • [49] FoxM1 is a Novel Target of a Natural Agent in Pancreatic Cancer
    Wang, Zhiwei
    Ahmad, Aamir
    Banerjee, Sanjeev
    Azmi, Asfar
    Kong, Dejuan
    Li, Yiwei
    Sarkar, Fazlul H.
    PHARMACEUTICAL RESEARCH, 2010, 27 (06) : 1159 - 1168
  • [50] Negative regulation of the oncogenic transcription factor FoxM1 by thiazolidinediones and mithramycin
    Petrovic, Vladimir
    Costa, Robert H.
    Lau, Lester F.
    Raychaudhuri, Pradip
    Tyner, Angela L.
    CANCER BIOLOGY & THERAPY, 2010, 9 (12) : 1008 - 1016